- Home
- BTMD
BTMD
Biote Corp.
as 07-26-2024 4:00pm EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 224.1M | IPO Year: | N/A |
| Target Price: | $8.11 | AVG Volume (30 days): | 299.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.65 - $8.44 | Next Earning Date: | 08-08-2024 |
| Revenue: | $187,321,000 | Revenue Growth: | 8.49% |
| Revenue Growth (this year): | 11.18% | Revenue Growth (next year): | 15.95% |
Stock Insider Trading Activity of Biote Corp. (BTMD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Peterson Robert Charles | BTMD | Chief Financial Officer | Jul 8 '24 | Sell | $7.57 | 11,376 | $86,084.47 | 32,874 | SEC Form 4 |
Latest Biote Corp. News
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call
Zacks
9 days ago
Zacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics
Zacks
10 days ago
5 Stocks With Recent Price Strength to Tap Wall Street Rally
Zacks
17 days ago
Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet
Zacks
a month ago
biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?
MT Newswires
a month ago
Biote Reaches $60 Million Settlement to Repurchase Shares From Stockholder
Business Wire
a month ago
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares
MT Newswires
2 months ago
Biote Shares Fall After Report by Short-Seller J Capital
Compare BTMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.